Circulating tumor DNA (ctDNA) monitoring in breast cancer patients receiving neoadjuvant palbociclib and endocrine therapy. A secondary analysis of the NeoRHEA phase 2 study
ASCO 2023
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients